Sarepta Therapeutics Inc. (SRPT) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Sarepta Therapeutics Inc. (SRPT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

127.89

-0.06%

After-hours Jan 06, 2025, 04:07 PM EST

Sarepta Therapeutics Inc. Revenue Breakdown

Quarter	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
A M O N D Y S Fourty Five Revenue	26.66M	6.94M	193.00K
A M O N D Y S Fourty Five Revenue Growth	+284.30%	+3493.78%	n/a
E X O N D Y S Fifty One Revenue	115.60M	112.46M	107.19M
E X O N D Y S Fifty One Revenue Growth	+2.79%	+4.92%	n/a
V Y O N D Y S Fifty Three Revenue	24.66M	22.44M	17.55M
V Y O N D Y S Fifty Three Revenue Growth	+9.87%	+27.89%	n/a

Revenue by Geography

Quarter	Dec 31, 2023	Dec 31, 2022
United States Revenue	797.94M	747.10M
United States Revenue Growth	+6.81%	n/a
Rest Of World Revenue	146.58M	n/a
Rest Of World Revenue Growth	n/a	n/a

Operating Expense Breakdown

Quarter	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	128.20M	136.66M	127.00M	131.70M	120.89M	118.56M	110.71M	120.48M	104.79M	154.32M	71.84M	78.06M	61.13M	72.35M	71.13M	86.05M	75.37M	73.69M	82.77M	81.42M	75.43M	67.39M	60.57M	64.22M	53.04M	49.38M	43.34M	32.22M	28.18M	36.07M	26.22M	22.94M	22.18M	17.75M	20.88M	24.33M	15.09M	12.93M	22.70M
Selling, General, and Administrative Revenue Growth	-6.19%	+7.60%	-3.57%	+8.94%	+1.96%	+7.09%	-8.10%	+14.97%	-32.10%	+114.81%	-7.96%	+27.69%	-15.51%	+1.71%	-17.33%	+14.16%	+2.29%	-10.97%	+1.65%	+7.95%	+11.92%	+11.27%	-5.69%	+21.07%	+7.42%	+13.93%	+34.51%	+14.36%	-21.88%	+37.58%	+14.30%	+3.39%	+24.97%	-14.96%	-14.19%	+61.23%	+16.73%	-43.05%	n/a
Research and Development Revenue	224.48M	173.71M	194.35M	195.52M	194.30M	241.89M	245.68M	213.80M	216.71M	252.33M	194.25M	197.30M	139.12M	239.62M	195.15M	207.24M	190.44M	188.52M	136.14M	223.14M	133.95M	113.27M	90.55M	146.21M	86.58M	122.85M	46.20M	44.44M	34.24M	58.91M	29.12M	70.75M	34.35M	44.35M	38.83M	41.38M	36.67M	29.18M	39.16M
Research and Development Revenue Growth	+29.23%	-10.62%	-0.60%	+0.63%	-19.67%	-1.54%	+14.91%	-1.34%	-14.12%	+29.90%	-1.54%	+41.82%	-41.94%	+22.79%	-5.83%	+8.82%	+1.02%	+38.47%	-38.99%	+66.59%	+18.26%	+25.08%	-38.07%	+68.86%	-29.52%	+165.88%	+3.97%	+29.80%	-41.88%	+102.30%	-58.84%	+105.97%	-22.55%	+14.22%	-6.16%	+12.82%	+25.68%	-25.49%	n/a